1. Anlotinib Inhibits Cell Proliferation, Migration and Invasion via Suppression of c-Met Pathway and Activation of ERK1/2 Pathway in H446 Cells
   Xiali Tang et al, 2021, Anti-Cancer Agents in Medicinal Chemistry CrossRef
2. Bioactivity Studies of Hesperidin and XAV939
   Ahmed E. Fazary et al, 2021, ACS Omega CrossRef
3. Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer
   Mingfeng Yu et al, 2022, Journal of Medicinal Chemistry CrossRef
4. Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance
   Maliheh Entezari et al, 2024, Current Cancer Drug Targets CrossRef
5. Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer
   Haixiang Yu et al, 2019, Canadian Respiratory Journal CrossRef
6. Wnt/β-catenin signaling pathway in lung cancer
   Wenhua Zhu et al, 2022, Medicine in Drug Discovery CrossRef